ARCHIVES

Campath Improves PFS In B-Cell CLL In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

Rabson’s Group Hears Suggestions On Carcinogenesis

November 25, 1977

NCI Bypass Budget Seeks $1 Billion Increase For FY 2011

February 26, 2010

NCAB Okays Effort To Relax $5 Million Limit On Center Core Grants In Cancer Act Renewal

November 19, 1976

Dole to Press HCFA On Community DRG Exemptions, Calls For Meeting TO Assess Problems

March 16, 1984

FDA Approves BMS’s Yervoy For Metastatic Melanoma

March 25, 2011

Clinton Declares Month of April Cancer Control Month

April 11, 1997